Clinical features | Specification | All | LTS (n = 91) | STS-1 (n = 91) | LTS (subgroup, n = 80) | STS-2 (n = 80) |
---|---|---|---|---|---|---|
KPS | Median (range) | 80 (30–100) | 80 (30–100) | 80 (40–100) | 70 (30–100) | 80 (30–100) |
Age | Median (range) | 55 (11–84) | 54 (22–77) | 56 (11–84) | 56 (22–77) | 55.5 (15–77) |
Gender (%) | Female | 42.7 | 45.1 | 52.7 | 42.5 | 28.8 |
Male | 57.3 | 54.9 | 47.3 | 57.5 | 71.3 | |
Surgery/biopsy (%) | Surgery | 94.7 | 94.5 | 94.5 | 95.0 | 95.0 |
Biopsy | 5.3 | 5.5 | 5.5 | 5.0 | 5.0 | |
Dose | Median (range) | 60 (7–68) | 60 (37.5–60) | 60 (16–68) | 60 (37.5–60) | 60 (7–62) |
Multifocal* (%) | Yes | 65.1 | 50.0 | 81.3 | 50.0 | 66.7 |
No | 34.9 | 50.0 | 18.8 | 50.0 | 33.3 |